Platinum TV Stand for TVs up to 50″ MooreCo

The Diagnostic Technologies Summit 2018 is the location to be for all those interested MooreCo in microfluidics, PCR and human healthcare. Worldwide Engage previews what to anticipate.

The part of health-related devices in healthcare systems is crucial, and, with new approvals, the diagnostic technology sector is growing now additional than ever. The microfluidic and PCR (polymerase chain reaction) sectors both hold terrific guarantee for the improvement of human healthcare and as such will type the basis of the Diagnostic Technologies Summit.


With the most recent advancements in lab-on-a-chip microfabrications, 3D printers, and micro-electromechanical systems, microfluidic technologies is set to revolutionise the platinum tv stand way individuals are diagnosed, monitored, and platinum tv stand treated. The microfluidic sector currently faces challenges with the improvement of 3D printing and the reliability of these devices. By bringing with each other professionals, we hope to discover the strategies and applications of existing microfluidic technologies.

qPCR and dPCR

There have also been current advances and approaches in quantitative PCR (qPCR) and digital PCR (dPCR) across areas such as oncology, infectious ailments, vaccines, clinical applications, and microbiology. Challenges take place as PCR and qPCR generate uncertainties and inaccuracies in their outcomes. dPCR, on the other hand, has been shown to be a promising surveillance tool for illnesses such as cancer. dPCR delivers far greater sensitivity and accuracy in the benefits. Due to these advancements in PCR, the industry is thriving.

All round, the diagnostic technologies sector holds terrific promise for advancement in human healthcare.

The Diagnostic Technologies Summit 2018

With these current advancements in thoughts, International Engage is pleased to announce the 2018 Diagnostic Technologies Summit. The summit will be bringing together over 180 market and academic professionals in each microfluidics and PCR.

It will be held on 13-14 September 2018 in San Francisco, USA, and is aspect of our profitable life science technologies series with a sister occasion in Europe in December.

What to count on from the presentations

Presentations will cover the most current developments and techniques in qPCR and dPCR and microfluidics across places such as oncology, infectious ailments, vaccines, clinical applications, nanotechnology, biotechnology, lab-on-a-chip fabrication, and microbiology. The two-day summit attributes 57 contributions across 5 streams exploring:

Digital PCR: possibilities and possibilities

  • Introduction, rewards, and future developments of dPCR
  • Comparing dPCR to qPCR
  • Converting to dPCR and deciding upon your system
  • Digital PCR workflow optimisation
  • Data analysis tools
  • Validation of dPCR for clinical and investigation use
  • Complementing dPCR with other technologies, which includes subsequent-generation sequencing (NGS)
  • Multiplexing in dPCR
  • Detection of uncommon/patient-distinct mutations
  • Applications for precision medicine and
  • Challenges of reproducibility/standardisation.

qPCR: strategies and developments

  • Developments in qPCR techniques
  • MIQE recommendations and standardisation
  • qPCR/RT-PCR assay design, optimisation, and validation
  • Sample preparation
  • Dealing with false positives and other good quality handle measures
  • Detection, quantification, and sequencing of RNA
  • Automation of qPCR techniques
  • Bioinformatics and data evaluation
  • Approaches for multiplexing
  • Combining qPCR with other technologies
  • Point-of-care diagnostics developments
  • Moving technologies from the lab to the clinic and
  • Challenges of reproducibility.

Microfluidics: technique and technologies

  • Lab-on-a-chip microfabrication
  • Substrate improvement (silicon, glass, paper, and polymer)
  • 3D printing
  • Digital microfluidics
  • Electrokinetics and electrohydrodynamics
  • Acoustofluidics and optofluidics
  • Droplet microfluidics
  • Centrifugal microfluidics and
  • Advances in microelectromechanical systems (MEMS).

Diagnostic case research

  • Companion diagnostics
  • Point-of-care research
  • Clinical test validation
  • Liquid biopsies
  • CTC/ctDNA/cfDNA/mtDNA-based testing
  • Disease monitoring
  • Higher-throughput screening
  • Single cell evaluation
  • Biomarker discovery
  • Micro-RNA/ncRNA/siRNA applications
  • Mutation detection
  • Therapy response monitoring
  • Rare variant detection
  • Early relapse detection and
  • Bioreactors.

Panel discussions: challenges of clinical implementation

  • Sensible restrictions
  • Reliability considerations
  • FDA approval procedure
  • What applications are ready for which technologies and
  • Case study evidence/clinical trials.

Who’s speaking at the event?

We will be welcoming more than 40 specialist speakers who specialise in lab-on-a-chip microfabrications, 3D printers, micro-electromechanical systems, oncology, infectious ailments, vaccines, clinical applications and microbiology. A snapshot of our speakers is supplied under.

Luke Lee, Arnold and Barbara Silverman Distinguished Professor of Bioengineering at the University of California, Berkeley, and director of the Biomedical Institute of Worldwide Healthcare Study &amp Technologies, will be opening the congress by sharing his research on personalised medicine by way of microfluidic biosensors and point-of-care diagnostics.

Carl Wittwer, healthcare director of Immunologic Flow Cytometry at Related Regional and University Pathologists, Salt Lake City, Utah, will share a presentation on fast diagnostics and the extreme PCR and higher-speed melting.

Adela Ben-Yakar, Mr N Doug Williams Memorial Centennial Fellow in Engineering at the University of Texas at Austin, focuses her study on massive-scale microfluidic systems for higher-throughput screenings of C. elegans disease models and regeneration research.

Juan Santiago, director of the Stanford Microfluidics Laboratory, California, will be speaking on separating and analysing nuclear versus cytoplasmic nucleic acids from single cells.

Ashleigh Theberge, assistant professor of chemistry at the University of Washington, studies cell signalling in complicated environments using open microfluidics – the manipulation of fluids with at MooreCo least 1 open air interface.

Hestia Mellert, director of molecular improvement at Biodesix, will speak on the development, commercialisation, and on-marketplace improvement of liquid diagnostic tests in
lung cancer.

As well as listening to these experts present on their investigation, we will also deliver an interactive networking forum to answer your queries.

Aims of the occasion

The extensive agenda has been created to provide professionals with an exceptional interdisciplinary atmosphere in which to debate the crucial challenges facing them now.

Covering the developments in microfluidics, qPCR, and dPCR, this summit will bring together more than 180 market and academic professionals to retain you up to date with cutting-edge study in new diagnostic technologies. The conference will deliver an interactive networking forum to each additional create and answer your queries by means of an exhibition room complete of technologies providers showcasing their technologies and other options in dedicated poster presentation sessions.

This meeting will give you the chance to make lasting connections with academics, entrepreneurs and enterprises in your field.

The 4Bio Summit

If you are unable to join us in San Francisco for the Diagnostic Technologies Summit, why not join us at the 4Bio Summit in Rotterdam, the Netherlands, in November. The 4Bio Summit will feature investigation and technologies developments in the fields of qPCR/dPCR, NGS, microfluidics, and gene editing. Scientific advancements coupled with cost reductions in these four regions of investigation have contributed to the enhanced diagnosis, monitoring, and therapy of disease.

With comparable and shared procedures across the four major themes of the meeting, the 4Bio Summit will provide a multidisciplinary forum in which to uncover crossover in your investigation. Attend the most recent cutting-edge talks, network with your peers, and uncover solutions to the entire spectrum of your research all in one place.

For more info on the Diagnostic Technologies Summit, take a look at the agenda or see our upcoming conferences on our site.

International Engage
The platinum tv stand Diagnostic Technologies Summit

This short article will appear in problem 5 of Health Europa Quarterly, which will be published in Might.

Subscribe to our newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *